|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Scientific Research Department, Armed Froces Radiobiology Research Institute, Bethesda, Maryland, United States; Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States; Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States; Cellular Injury, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States
2 US Army Institute of Surgical Research, Fort Sam Houston, Texas, United States
3 Cellular Injury, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States
4 Pharmacology, University of Minnesota, Annapolix, Minnesota, United States
5 Physics and Astronomy, Arizona State University, Tempe, Arizona, United States
6 Rheumatology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States
* To whom correspondence should be addressed. E-mail: kiangj{at}comcast.net.
Hemorrhage has been shown to increase iNOS and deplete ATP levels in tissues and geldanamycin limits both processes. Moreover, it is evident that inhibition of iNOS reduces caspase-3 and increases survival. Thus, we sought to identify the molecular events responsible for the beneficial effect of geldanamycin. Hemorrhage in mice significantly increased caspase-3 activity and protein while treatment with geldanamycin significantly limited these increases. Similarly, geldanamycin inhibited increases in proteins forming the apoptosome (a complex of caspase-9, cytochrome c, and Apaf-1). Modulation of the expression of iNOS by iNOS gene transfection or siRNA treatment demonstrated that the level of iNOS correlates with caspase-3 activity. Our data indicate that geldanamycin limits caspase-3 expression and protects from organ injury by suppressing iNOS expression and apoptosome formation. Geldananmycin, therefore, may prove useful as an adjuvant in fluids used to treat patients suffering blood loss.
This article has been cited by other articles:
![]() |
J. G. Kiang, S. Krishnan, X. Lu, and Y. Li Inhibition of Inducible Nitric-Oxide Synthase Protects Human T Cells from Hypoxia-Induced Apoptosis Mol. Pharmacol., March 1, 2008; 73(3): 738 - 747. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |